Found: 81
Select item for more details and to access through your institution.
Genetic Polymorphisms and Statin Therapy.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 11, p. 1302, doi. 10.1001/jama.292.11.1302-b
- By:
- Publication type:
- Article
CXCL5 Gene Polymorphism Association with Diabetes Mellitus.
- Published in:
- Molecular Diagnosis & Therapy, 2008, v. 12, n. 6, p. 391, doi. 10.1007/BF03256304
- By:
- Publication type:
- Article
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 536, doi. 10.1016/j.clpt.2004.08.020
- By:
- Publication type:
- Article
Reply<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 2, p. 186, doi. 10.1016/j.clpt.2004.04.008
- By:
- Publication type:
- Article
β<sub>1</sub>-Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 44, doi. 10.1016/S0009-9236(03)00068-7
- By:
- Publication type:
- Article
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 209, doi. 10.1007/s10741-008-9092-z
- By:
- Publication type:
- Article
Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e2351839, doi. 10.1001/jamanetworkopen.2023.51839
- By:
- Publication type:
- Article
New Genetic Discoveries and Treatment for Hepatitis C.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Pharmacogenetics of response to statins.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 3, p. 187, doi. 10.1007/s11883-007-0018-3
- By:
- Publication type:
- Article
Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 22, p. 1698, doi. 10.1093/jnci/djq390
- By:
- Publication type:
- Article
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Las t Poem I Write.
- Published in:
- 2022
- By:
- Publication type:
- Poem
Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation.
- Published in:
- Clinical Cardiology, 2009, v. 32, n. 5, p. 244, doi. 10.1002/clc.20454
- By:
- Publication type:
- Article
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril Study (INVEST).
- Published in:
- Clinical Cardiology, 2005, v. 28, n. 7, p. 321, doi. 10.1002/clc.4960280704
- By:
- Publication type:
- Article
Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 8, p. 729, doi. 10.1592/phco.31.8.729
- By:
- Publication type:
- Article
Pharmacodynamic Effects of Rosiglitazone in Nondiabetic Patients with Metabolic Syndrome.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 3, p. 236, doi. 10.1592/phco.30.3.236
- By:
- Publication type:
- Article
Key Articles Relative to Cardiovascular Pharmacogenomics.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 9, p. 1110, doi. 10.1592/phco.29.9.1110
- By:
- Publication type:
- Article
Evaluation of Immunomodulatory Biomarkers in a Pressure Overload Model of Heart Failure.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 4, p. 504, doi. 10.1592/phco.27.4.504
- By:
- Publication type:
- Article
Complementary and Alternative Medicine Use Among Individuals Participating in Research: Implications for Research and Practice.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 12, p. 1794, doi. 10.1592/phco.26.12.1794
- By:
- Publication type:
- Article
Atorvastatin Effect on Circulating and Leukocyte-Produced CD40 Ligand Concentrations in People with Normal Cholesterol Levels: A Pilot Study.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 11, p. 1572, doi. 10.1592/phco.26.11.1572
- By:
- Publication type:
- Article
Discordant β-Blocker Effects on Clinic, Ambulatory, Resting, and Exercise Hemodynamics in Patients with Hypertension.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 9, p. 1247, doi. 10.1592/phco.26.9.1247
- By:
- Publication type:
- Article
Modulatory Effects of Atorvastatin on Endothelial Cell-Derived Chemokines, Cytokines, and Angiogenic Factors.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 3, p. 333, doi. 10.1592/phco.26.3.333
- By:
- Publication type:
- Article
Pharmacoeconomic Modeling of Nesiritide versus Dobutamine for Decompensated Heart Failure.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 1, p. 34, doi. 10.1592/phco.2006.26.1.34
- By:
- Publication type:
- Article
Modulatory Effect of Fenofibrate on Endothelial Production of Neutrophil Chemokines IL-8 and ENA-78.
- Published in:
- Cardiovascular Drugs & Therapy, 2012, v. 26, n. 2, p. 95, doi. 10.1007/s10557-011-6368-7
- By:
- Publication type:
- Article
Genetic and Pharmacogenetic Associations Between NOS3 Polymorphisms, Blood Pressure, and Cardiovascular Events in Hypertension.
- Published in:
- American Journal of Hypertension, 2009, v. 22, n. 7, p. 748, doi. 10.1038/ajh.2009.81
- By:
- Publication type:
- Article
Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins.
- Published in:
- PLoS ONE, 2008, v. 3, n. 9, p. 1, doi. 10.1371/journal.pone.0003117
- By:
- Publication type:
- Article
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
- Published in:
- Journal of Translational Medicine, 2008, v. 6, p. 1, doi. 10.1186/1479-5876-6-11
- By:
- Publication type:
- Article
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding.
- Published in:
- Human Reproduction, 2006, v. 21, n. 10, p. 2555, doi. 10.1093/humrep/del206
- By:
- Publication type:
- Article
Statin Drug‐Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical Resources.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 6, p. 704, doi. 10.1002/jcph.2406
- By:
- Publication type:
- Article
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 695, doi. 10.1002/jcph.2208
- By:
- Publication type:
- Article
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy‐Induced Nausea and Vomiting.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 6, p. 775, doi. 10.1002/jcph.1577
- By:
- Publication type:
- Article
The Evolving Role of Nesiritide in Advanced or Decompensated Heart Failure.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1266, doi. 10.1592/phco.23.12.1266.32705
- By:
- Publication type:
- Article
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors.
- Published in:
- AAPS Journal, 2020, v. 22, n. 2, p. 1, doi. 10.1208/s12248-020-0433-8
- By:
- Publication type:
- Article
Precision Dosing: A Clinical and Public Health Imperative.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Biosimilarity Concept: Toward an Integrated Framework for Evidence Assessment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
How debunking biases in research and development decisions could lead to more equitable healthcare?
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13880
- By:
- Publication type:
- Article
Common laboratory methods in pharmacogenomics studies.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 21, p. 2101, doi. 10.2146/ajhp060068
- By:
- Publication type:
- Article
The ICD Shock and Stress Management Program: A Randomized Trial of Psychosocial Treatment to Optimize Quality of Life in ICD Patients.
- Published in:
- Pacing & Clinical Electrophysiology, 2007, v. 30, n. 7, p. 858, doi. 10.1111/j.1540-8159.2007.00773.x
- By:
- Publication type:
- Article
The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 278, doi. 10.1002/cpt.3228
- By:
- Publication type:
- Article
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID‐19 Under the Emergency Use Authorization.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 890, doi. 10.1002/cpt.3191
- By:
- Publication type:
- Article
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 440, doi. 10.1002/cpt.3178
- By:
- Publication type:
- Article
A Multistakeholder Perspective on Advancing Individualized Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 994, doi. 10.1002/cpt.3030
- By:
- Publication type:
- Article
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with PCSK9 Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 71, doi. 10.1002/cpt.2769
- By:
- Publication type:
- Article
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 55, doi. 10.1002/cpt.2761
- By:
- Publication type:
- Article
Model‐Based Approach to Selecting Pegfilgrastim Dose for Pharmacokinetic and Pharmacodynamic Similarity Studies in Biosimilar Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 62, doi. 10.1002/cpt.2722
- By:
- Publication type:
- Article
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 285, doi. 10.1002/cpt.2151
- By:
- Publication type:
- Article
Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and Commitments.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 697, doi. 10.1002/cpt.2038
- By:
- Publication type:
- Article
A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response‐Guided Titration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 123, doi. 10.1002/cpt.2068
- By:
- Publication type:
- Article